All In Biotech

Drug Trial Radar · NCT00430118

Combination Chemotherapy Based on Risk of Relapse in Treating Young Patients With Acute Lymphoblastic Leukemia

ALL-BFM 2000 Multi-Center Study for the Treatment of Children and Adolescents With Acute Lymphoblastic Leukemia

Last checked: Nov 19, 2026Latest source record: May 29, 2013 (this record)Source: ClinicalTrials.govMethods & limitations

CompletedPivotal-lookingPhase 3. Randomized with 4,559 participants. This is a heuristic, not a regulatory label.

Status

Completed

Enrollment

4,559

Actual

Start

Jul 2000

Primary completion

Jan 2012

Study completion Jan 2012

Sponsor

Lead sponsor
University Hospital Schleswig-HolsteinAcademic, hospital or other
Sponsor type
Academic, hospital or other
First posted
Feb 1, 2007

More drug trials from this sponsor

Design

Study type
Interventional
Phase
Phase 3
Allocation
Randomized
Model
Factorial
Masking
None
Primary purpose
Treatment
Who can join
All sexes, from 1 year, up to 18 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

RATIONALE: Drugs used in chemotherapy work in different ways to stop the growth of cancer cells, either by killing the cells or by stopping them from dividing. Giving more than one drug (combination chemotherapy) may kill more cancer cells. It is not yet known which combination chemotherapy regimen is more effective in treating young patients with acute lymphoblastic leukemia. PURPOSE: Thisphase III trial is studying several different combination chemotherapy regimens to compare how well they work in treating young patients with acute lymphoblastic leukemia.

Conditions

  • Leukemia

Interventions

  • asparaginaseDrug

  • cyclophosphamideDrug

  • cytarabineDrug

  • daunorubicin hydrochlorideDrug

  • dexamethasoneDrug

  • doxorubicin hydrochlorideDrug

  • etoposideDrug

  • ifosfamideDrug

  • mercaptopurineDrug

  • methotrexateDrug

  • prednisoneDrug

  • thioguanineDrug

  • vincristine sulfateDrug

  • vindesineDrug

  • radiation therapyRadiation

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Efficacy of dexamethasone vs prednisone during the induction phaseTime frame: End of Trial
  2. Event-free survival (EFS) and overall survival after initial remission in intermediate-risk and high-risk patientsTime frame: End of Trial
  3. Safety and efficacy of treatment reduction during reintensification in standard-risk patientsTime frame: End of Trial
  4. EFS after second delayed reintensification in intermediate-risk patientsTime frame: End of Trial
  5. Outcome after extended reintensification therapy in high-risk patientsTime frame: End of Trial

Locations

76 sites in 3 countries. Site status is shown where the registry gives one.

  • Krankenhaus Dornbirn

    Dornbirn, Austria

  • Landeskrankenhaus Feldkirch

    Feldkirch-Tisis, Austria

  • Universitaet Kinderklinik

    Graz, Austria

  • Innsbruck Universitaetsklinik

    Innsbruck, Austria

  • Landeskrankenhaus Klagenfurt

    Klagenfurt, Austria

  • LKH Leoben

    Leoben, Austria

  • A. oe. Krankenhaus der Barmherzigen Schwestern Kinderabteilung

    Linz, Austria

  • Landes-Kinderkrankenhaus

    Linz, Austria

  • St. Johanns-Spital

    Salzburg, Austria

  • St. Anna Children's Hospital

    Vienna, Austria

  • Kinderklinik - Universitaetsklinikum Aachen

    Aachen, Germany

  • Klinikum Augsburg

    Augsburg, Germany

  • Caritas-Krankenhaus Bad Mergentheim

    Bad Mergentheim, Germany

  • Klinikum Bayreuth

    Bayreuth, Germany

  • Helios Klinikum Berlin

    Berlin, Germany

  • Charite University Hospital - Campus Virchow Klinikum

    Berlin, Germany

  • Kinderklinik der Universitaet Bonn

    Bonn, Germany

  • Staedtisches Klinikum - Howedestrase

    Braunschweig, Germany

  • Klinikum Chemnitz gGmbH

    Chemnitz, Germany

  • Klinikum Coburg

    Coburg, Germany

  • Kliniken der Stadt Koeln gGmbH - Kinderkrankenhaus Riehl

    Cologne, Germany

  • Children's Hospital

    Cologne, Germany

  • Carl - Thiem - Klinkum Cottbus

    Cottbus, Germany

  • Vestische Kinderklinik Universitaetsklinik Witten/Herdecke

    Datteln, Germany

  • Klinikum Lippe - Detmold

    Detmold, Germany

  • Klinikum Dortmund

    Dortmund, Germany

  • Universitatsklinikum Carl Gustav Carus

    Dresden, Germany

  • Klinikum Duisburg

    Duisburg, Germany

  • Helios Klinikum Erfurt

    Erfurt, Germany

  • Universitaets - Kinderklinik

    Erlangen, Germany

  • Universitaetsklinikum Essen

    Essen, Germany

  • Klinikum der J.W. Goethe Universitaet

    Frankfurt, Germany

  • Universitaetskinderklinik - Universitaetsklinikum Freiburg

    Freiburg im Breisgau, Germany

  • Kinderklinik

    Giessen, Germany

  • Universitaetsklinikum Goettingen

    Göttingen, Germany

  • Universitaetsklinikum Halle

    Halle, Germany

  • Medizinische Hochschule Hannover

    Hanover, Germany

  • Universitaets-Kinderklinik Heidelberg

    Heidelberg, Germany

  • SLK - Kliniken Heilbronn GmbH - Klinikum am Gesundbrunnen

    Heilbronn, Germany

  • Gemeinschaftskrankenhaus

    Herdecke, Germany

Showing 40 of 76 sites, US sites first. The full list is on the registry record.

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.